Aletho News

ΑΛΗΘΩΣ

Industry: biometrics business valued at $10 billion by 2018

According to a new report published by Global Industry Analysts, Inc., the President and CEO of biometrics firm SmartMetric posits that the industry will be worth $10 billion by 2018. 

SmartMetric, of course, “stands to capitalize significantly on this very large and fast growing market,” so perhaps that projection should be taken with a grain of salt.

But specific figures aside, the industry is undoubtedly booming, and in large part due to US military and law enforcement biometrics programs.

The FBI’s Next Generation Identification biometrics effort, housed in the Center for Biometric Excellence at the FBI-DoD operated Biometrics Technology Center, is the largest domestic operation. Local law enforcement are increasingly also using advanced biometric monitoring equipment, including face recognition and iris scanners.

If you are worried about how powerful biometrics technologies might be used in your city or state, click here to find out how to get involved at the local level to ensure police transparency and democratic accountability.

On the Wish List from the Boston Bombings – The Israelization of America

April 17, 2013 Posted by | Civil Liberties, Full Spectrum Dominance, Timeless or most popular, Video | , , , , , , , | Leave a comment

Tales of Reagan’s Guatemala Genocide

By Robert Parry | Consortium News | April 16, 2013

The first month of the genocide trial of former Guatemalan dictator Efrain Rios Montt has elicited chilling testimony from Mayan survivors who – as children – watched their families slaughtered by a right-wing military that was supported and supplied by U.S. President Ronald Reagan.

As the New York Times reported on Monday, “In the tortured logic of military planning documents conceived under Mr. Ríos Montt’s 17-month rule during 1982 and 1983, the entire Mayan Ixil population was a military target, children included. Officers wrote that the leftist guerrillas fighting the government had succeeded in indoctrinating the impoverished Ixils and reached ‘100 percent support.’”

President Ronald Reagan meeting with Guatemalan dictator Efrain Rios Montt.

So, everyone was targeted in these scorched-earth campaigns that eradicated more than 600 Indian villages in the Guatemalan highlands. But this genocide was not simply the result of a twisted anticommunist ideology that dominated the Guatemalan military and political elites. This genocide also was endorsed by the Reagan administration.

A document that I discovered recently in the archives of the Reagan Library in Simi Valley, California, revealed that Reagan and his national security team in 1981 agreed to supply military aid to the brutal right-wing regime in Guatemala to pursue the goal of exterminating not only “Marxist guerrillas” but people associated with their “civilian support mechanisms.”

This supportive attitude toward the Guatemalan regime’s brutality took shape in spring 1981 as President Reagan sought to ease human-rights restrictions on military aid to Guatemala that had been imposed by President Jimmy Carter and the Democratic-controlled Congress in the late 1970s.

As part of that relaxation effort, Reagan’s State Department “advised our Central American embassies that it has been studying ways to restore a closer, cooperative relationship with Guatemala,” according to a White House “Situation Room Checklist” dated April 8, 1981. The document added:

“State believes a number of changes have occurred which could make Guatemalan leaders more receptive to a new U.S. initiative: the Guatemalans view the new administration as more sympathetic to their problems [and] they are less suspect of the U.S. role in El Salvador,” where the Reagan administration was expanding support for another right-wing regime infamous for slaughtering its political opponents, including Catholic clergy.

“State has concluded that any attempt to reestablish a dialogue [with Guatemala] would require some initial, condition-free demonstration of our goodwill. However, this could not include military sales which would provoke serious U.S. public and congressional criticism. State will undertake a series of confidence building measures, free of preconditions, which minimize potential conflict with existing legislation.”

The “checklist” added that the State Department “has also decided that the administration should engage the Guatemalan government at the highest level in a dialogue on our bilateral relations and the initiatives we can take together to improve them. Secretary [of State Alexander] Haig has designated [retired] General Vernon Walters as his personal emissary to initiate this process with President [Fernando Romeo] Lucas [Garcia].

“If Lucas is prepared to give assurances that he will take steps to halt government involvement in the indiscriminate killing of political opponents and to foster a climate conducive to a viable electoral process, the U.S. will be prepared to approve some military sales immediately.”

But the operative word in that paragraph was “indiscriminate.” The Reagan administration expressed no problem with killing civilians if they were considered supporters of the guerrillas who had been fighting against the country’s ruling oligarchs and generals since the 1950s when the CIA organized the overthrow of Guatemala’s reformist President Jacobo Arbenz.

Sympathy for the Generals

The distinction was spelled out in “Talking Points” for Walters to deliver in a face-to-face meeting with General Lucas. As edited inside the White House in April 1981, the “Talking Points” read: “The President and Secretary Haig have designated me [Walters] as [their] personal emissary to discuss bilateral relations on an urgent basis.

“Both the President and the Secretary recognize that your country is engaged in a war with Marxist guerrillas. We are deeply concerned about externally supported Marxist subversion in Guatemala and other countries in the region. As you are aware, we have already taken steps to assist Honduras and El Salvador resist this aggression.

“The Secretary has sent me here to see if we can work out a way to provide material assistance to your government. … We have minimized negative public statements by US officials on the situation in Guatemala. … We have arranged for the Commerce Department to take steps that will permit the sale of $3 million worth of military trucks and Jeeps to the Guatemalan army. …

“With your concurrence, we propose to provide you and any officers you might designate an intelligence briefing on regional developments from our perspective. Our desire, however, is to go substantially beyond the steps I have just outlined. We wish to reestablish our traditional military supply and training relationship as soon as possible.

“As we are both aware, this has not yet been feasible because of our internal political and legal constraints relating to the use by some elements of your security forces of deliberate and indiscriminate killing of persons not involved with the guerrilla forces or their civilian support mechanisms. I am not referring here to the regrettable but inevitable death of innocents through error in combat situations, but to what appears to us a calculated use of terror to immobilize non politicized people or potential opponents. …

“If you could give me your assurance that you will take steps to halt official involvement in the killing of persons not involved with the guerrilla forces or their civilian support mechanism … we would be in a much stronger position to defend successfully with the Congress a decision to begin to resume our military supply relationship with your government.”

In other words, though the “talking points” were framed as an appeal to reduce the “indiscriminate” slaughter of “non politicized people,” they amounted to an acceptance of scorched-earth tactics against people involved with the guerrillas and “their civilian support mechanisms.” The way that played out in Guatemala – as in nearby El Salvador – was the massacring of peasants in regions considered sympathetic to leftist insurgents.

The newly discovered documents – and other records declassified in the late 1990s – make clear that Reagan and his administration were well aware of the butchery underway in Guatemala and elsewhere in Central America.

According to one “secret” cable also from April 1981 — and declassified in the 1990s — the CIA was confirming Guatemalan government massacres even as Reagan was moving to loosen the military aid ban. On April 17, 1981, a CIA cable described an army massacre at Cocob, near Nebaj in the Ixil Indian territory, because the population was believed to support leftist guerrillas.

A CIA source reported that “the social population appeared to fully support the guerrillas” and “the soldiers were forced to fire at anything that moved.” The CIA cable added that “the Guatemalan authorities admitted that ‘many civilians’ were killed in Cocob, many of whom undoubtedly were non-combatants.” [Many of the Guatemalan documents declassified in the 1990s can be found at the National Security Archive’s Web site.]

Dispatching Walters

In May 1981, despite the ongoing atrocities, Reagan dispatched Walters to tell the Guatemalan leaders that the new U.S. administration wanted to lift the human rights embargoes on military equipment that Carter and Congress had imposed.

The “Talking Points” also put the Reagan administration in line with the fiercely anticommunist regimes elsewhere in Latin America, where right-wing “death squads” operated with impunity liquidating not only armed guerrillas but civilians who were judged sympathetic to left-wing causes like demanding greater economic equality and social justice.

Despite his aw shucks style, Reagan found virtually every anticommunist action justified, no matter how brutal. From his eight years in the White House, there is no historical indication that he was morally troubled by the bloodbath and even genocide that occurred in Central America while he was shipping hundreds of millions of dollars in military aid to the implicated forces.

The death toll was staggering — an estimated 70,000 or more political killings in El Salvador, possibly 20,000 slain from the Contra war in Nicaragua, about 200 political “disappearances” in Honduras and some 100,000 people eliminated during a resurgence of political violence in Guatemala. The one consistent element in these slaughters was the overarching Cold War rationalization, emanating in large part from Ronald Reagan’s White House.

Despite their claims to the contrary, the evidence is now overwhelming that Reagan and his advisers knew the extraordinary brutality going on in Guatemala and elsewhere, based on their own internal documents.

According to a State Department cable on Oct. 5, 1981, when Guatemalan leaders met again with Walters, they left no doubt about their plans. The cable said Gen. Lucas “made clear that his government will continue as before — that the repression will continue. He reiterated his belief that the repression is working and that the guerrilla threat will be successfully routed.”

Human rights groups saw the same picture. The Inter-American Human Rights Commission released a report on Oct. 15, 1981, blaming the Guatemalan government for “thousands of illegal executions.” [Washington Post, Oct. 16, 1981]

But the Reagan administration was set on whitewashing the ugly scene. A State Department “white paper,” released in December 1981, blamed the violence on leftist “extremist groups” and their “terrorist methods” prompted and supported by Cuba’s Fidel Castro.

What the documents from the Reagan Library make clear is that the administration was not simply struggling ineffectively to rein in these massacres – as the U.S. press corps typically reported – but was fully on board with the slaughter of people who were part of the guerrillas’ “civilian support mechanisms.”

U.S. intelligence agencies continued to pick up evidence of these government-sponsored massacres. One CIA report in February 1982 described an army sweep through the so-called Ixil Triangle in central El Quiche province.

“The commanding officers of the units involved have been instructed to destroy all towns and villages which are cooperating with the Guerrilla Army of the Poor [the EGP] and eliminate all sources of resistance,” the report said. “Since the operation began, several villages have been burned to the ground, and a large number of guerrillas and collaborators have been killed.”

The CIA report explained the army’s modus operandi: “When an army patrol meets resistance and takes fire from a town or village, it is assumed that the entire town is hostile and it is subsequently destroyed.” When the army encountered an empty village, it was “assumed to have been supporting the EGP, and it is destroyed. There are hundreds, possibly thousands of refugees in the hills with no homes to return to. …

“The army high command is highly pleased with the initial results of the sweep operation, and believes that it will be successful in destroying the major EGP support area and will be able to drive the EGP out of the Ixil Triangle. … The well documented belief by the army that the entire Ixil Indian population is pro-EGP has created a situation in which the army can be expected to give no quarter to combatants and non-combatants alike.”

On Feb. 2, 1982, Richard Childress, one of Reagan’s national security aides, wrote a “secret” memo to his colleagues summing up this reality on the ground:

“As we move ahead on our approach to Latin America, we need to consciously address the unique problems posed by Guatemala. Possessed of some of the worst human rights records in the region, … it presents a policy dilemma for us. The abysmal human rights record makes it, in its present form, unworthy of USG [U.S. government] support. …

“Beset by a continuous insurgency for at least 15 years, the current leadership is completely committed to a ruthless and unyielding program of suppression. Hardly a soldier could be found that has not killed a ‘guerrilla.’”

The Rise of Rios Montt

However, Reagan remained committed to supplying military hardware to Guatemala’s brutal regime. So, the administration welcomed Gen. Efrain Rios Montt’s March 1982 overthrow of the thoroughly bloodstained Gen. Lucas.

An avowed fundamentalist Christian, Rios Montt impressed Official Washington where the Reagan administration immediately revved up its propaganda machinery to hype the new dictator’s “born-again” status as proof of his deep respect for human life. Reagan hailed Rios Montt as “a man of great personal integrity.”

By July 1982, however, Rios Montt had begun a new scorched-earth campaign called his “rifles and beans” policy. The slogan meant that pacified Indians would get “beans,” while all others could expect to be the target of army “rifles.” In October, Rios Montt secretly gave carte blanche to the feared “Archivos” intelligence unit to expand “death squad” operations in the cities. Based at the Presidential Palace, the “Archivos” masterminded many of Guatemala’s most notorious assassinations.

The U.S. embassy was soon hearing more accounts of the army conducting Indian massacres, but ideologically driven U.S. diplomats fed the Reagan administration the propaganda spin that would be best for their careers. On Oct. 22, 1982, embassy staff dismissed the massacre reports as communist-inspired “disinformation campaign,” concluding that “that a concerted disinformation campaign is being waged in the U.S. against the Guatemalan government by groups supporting the communist insurgency in Guatemala.”

Reagan personally joined this P.R. campaign seeking to discredit human rights investigators and others who were reporting accurately about massacres that the administration knew, all too well, were true.

On Dec. 4, 1982, after meeting with Rios Montt, Reagan hailed the general as “totally dedicated to democracy” and added that Rios Montt’s government had been “getting a bum rap” on human rights. Reagan discounted the mounting reports of hundreds of Maya villages being eradicated.

In February 1983, however, a secret CIA cable noted a rise in “suspect right-wing violence” with kidnappings of students and teachers. Bodies of victims were appearing in ditches and gullies. CIA sources traced these political murders to Rios Montt’s order to the “Archivos” in October to “apprehend, hold, interrogate and dispose of suspected guerrillas as they saw fit.”

Despite these grisly facts on the ground, the annual State Department human rights survey praised the supposedly improved human rights situation in Guatemala. “The overall conduct of the armed forces had improved by late in the year” 1982, the report stated.

A different picture — far closer to the secret information held by the U.S. government — was coming from independent human rights investigators. On March 17, 1983, Americas Watch condemned the Guatemalan army for human rights atrocities against the Indian population.

New York attorney Stephen L. Kass said these findings included proof that the government carried out “virtually indiscriminate murder of men, women and children of any farm regarded by the army as possibly supportive of guerrilla insurgents.”

Rural women suspected of guerrilla sympathies were raped before execution, Kass said, adding that children were “thrown into burning homes. They are thrown in the air and speared with bayonets. We heard many, many stories of children being picked up by the ankles and swung against poles so their heads are destroyed.” [AP, March 17, 1983]

Putting on a Happy Face

Publicly, senior Reagan officials continued to put on a happy face. In June 1983, special envoy Richard B. Stone praised “positive changes” in Rios Montt’s government, and Rios Montt pressed the United States for 10 UH-1H helicopters and six naval patrol boats, all the better to hunt guerrillas and their sympathizers.

Since Guatemala lacked the U.S. Foreign Military Sales credits or the cash to buy the helicopters, Reagan’s national security team looked for unconventional ways to arrange the delivery of the equipment that would give the Guatemalan army greater access to mountainous areas where guerrillas and their civilian supporters were hiding.

On Aug. 1, 1983, National Security Council aides Oliver North and Alfonso Sapia-Bosch reported to National Security Advisor William P. Clark that his deputy Robert “Bud” McFarlane was planning to exploit his Israeli channels to secure the helicopters for Guatemala. [For more on McFarlanes’s Israeli channels, see Consortiumnews.com’sHow Neocons Messed Up the Mideast.”]

“With regard to the loan of ten helicopters, it is [our] understanding that Bud will take this up with the Israelis,” wrote North and Sapia-Bosch. “There are expectations that they would be forthcoming. Another possibility is to have an exercise with the Guatemalans. We would then use US mechanics and Guatemalan parts to bring their helicopters up to snuff.”

However, more political changes were afoot in Guatemala. Rios Montt’s vengeful Christian fundamentalism had hurtled so out of control, even by Guatemalan standards, that Gen. Oscar Mejia Victores seized power in another coup on Aug. 8, 1983.

Despite the power shift, Guatemalan security forces continued to murder with impunity, finally going so far that even the U.S. Embassy objected. When three Guatemalans working for the U.S. Agency for International Development were slain in November 1983, U.S. Ambassador Frederic Chapin suspected that “Archivos” hit squads were sending a message to the United States to back off even mild pressure for human rights.

In late November, in a brief show of displeasure, the administration postponed the sale of $2 million in helicopter spare parts. The next month, however, Reagan sent the spare parts anyway. In 1984, Reagan succeeded, too, in pressuring Congress to approve $300,000 in military training for the Guatemalan army.

By mid-1984, Chapin, who had grown bitter about the army’s stubborn brutality, was gone, replaced by a far-right political appointee named Alberto Piedra, who favored increased military assistance to Guatemala. In January 1985, Americas Watch issued a report observing that Reagan’s State Department “is apparently more concerned with improving Guatemala’s image than in improving its human rights.”

It was not until 1999, a decade after Ronald Reagan left office, that the shocking scope of the atrocities in Guatemala was publicly revealed by a truth commission that drew heavily on U.S. government documents that President Bill Clinton had ordered declassified.

On Feb. 25, 1999, the Historical Clarification Commission estimated that the 34-year civil war had claimed the lives of some 200,000 people with the most savage bloodletting occurring in the 1980s. The panel estimated that the army was responsible for 93 percent of the killings and leftist guerrillas for three percent. Four percent were listed as unresolved.

The report documented that in the 1980s, the army committed 626 massacres against Mayan villages. “The massacres that eliminated entire Mayan villages … are neither perfidious allegations nor figments of the imagination, but an authentic chapter in Guatemala’s history,” the commission concluded.

The army “completely exterminated Mayan communities, destroyed their livestock and crops,” the report said. In the northern highlands, the report termed the slaughter “genocide.” [Washington Post, Feb. 26, 1999]

Besides carrying out murder and “disappearances,” the army routinely engaged in torture and rape. “The rape of women, during torture or before being murdered, was a common practice” by the military and paramilitary forces, the report found.

The report added that the “government of the United States, through various agencies including the CIA, provided direct and indirect support for some [of these] state operations.” The report concluded that the U.S. government also gave money and training to a Guatemalan military that committed “acts of genocide” against the Mayans. [NYT, Feb. 26, 1999]

During a visit to Central America, on March 10, 1999, President Clinton apologized for the past U.S. support of right-wing regimes in Guatemala dating back to 1954. “For the United States, it is important that I state clearly that support for military forces and intelligence units which engaged in violence and widespread repression was wrong, and the United States must not repeat that mistake,” Clinton said. [Washington Post, March 11, 1999]

Impunity for Reagan’s Team

However, back in Washington, there was no interest in holding anyone accountable for aiding and abetting genocide. The story of the Guatemalan butchery and the Reagan administration’s complicity quickly disappeared into the great American memory hole.

For human rights crimes in the Balkans and in Africa, the United States has demanded international tribunals to arrest and to try violators and their political patrons for war crimes. In Iraq, President George W. Bush celebrated the trial and execution of Iraqi dictator Saddam Hussein for politically motivated killings.

Even Rios Montt, now 86, after years of evading justice under various amnesties, was finally indicted in Guatemala in 2012 for genocide and crimes against humanity. The first month of his trial has added eyewitness testimony to the atrocities that the Guatemalan military inflicted and that Ronald Reagan assisted and covered up.

On Monday, the New York Times reported on some of this painful testimony, but – as is almost always the case – the Times did not mention the role of Reagan and his administration. However, what the Times did include was chilling, including accounts from witnesses who as children fled to mountain forests to escape the massacres:

“Pedro Chávez Brito told the court that he was only six or seven years old when soldiers killed his mother. He hid in the chicken coop with his older sister, her newborn and his younger brother, but soldiers found them and dragged them out, forcing them back into their house and setting it on fire.

“Mr. Chávez says he was the only one to escape. ‘I got under a tree trunk and I was like an animal,’ Mr. Chávez told the court. ‘After eight days I went to live in the mountains. In the mountain we ate only roots and grass.’”

Lawyers for Rios Montt and his co-defendant, former intelligence chief José Mauricio Rodríguez Sánchez, have maintained that the pair did not order the killings, which they instead blamed on over-zealous field commanders.

However, the Times reported that “prosecution witnesses said the military considered Ixil civilians, including children, as legitimate targets. ‘The army’s objective with the children was to eliminate the seed for future guerrillas,’ Marco Tulio Alvarez, the former director of Guatemala’s Peace Archives, testified last week. ‘They used them to get information and to draw their parents to military centers where they arrested them.’

“In a study of 420 bodies exhumed from the Ixil region and presumed to date from the Ríos Montt period, experts found that almost 36 percent of those who were killed were under 18 years old, including some newborns.

“Jacinto Lupamac Gómez said he was eight when soldiers killed his parents and older siblings and hustled him and his two younger brothers into a helicopter. Like some of the children whose lives were spared, they were adopted by Spanish-speaking families and forgot how to speak Ixil.”

Though some belated justice may still be possible in Guatemala, there is no talk in the United States about seeking any accountability from the Reagan administration officials who arranged military assistance to this modern genocide or who helped conceal the atrocities while they were underway.

There has been no attention given by the mainstream U.S. news media to the new documents revealing how the Reagan administration gave a green light to the slaughter of Guatemalans who were considered part of the “civilian support mechanisms” for the Mayan guerrillas resisting the right-wing repression.

Ronald Reagan, the U.S. official most culpable for aiding and abetting the Guatemalan genocide, remains a hero to much of America with his name attached to Washington’s National Airport and scores of other government facilities. U.S. officials and many Americans apparently don’t want to disrupt their happy memories of the Gipper.

~

Investigative reporter Robert Parry broke many of the Iran-Contra stories for The Associated Press and Newsweek in the 1980s. You can buy his new book, America’s Stolen Narrative, either in print here or as an e-book (from Amazon and barnesandnoble.com).

April 17, 2013 Posted by | Ethnic Cleansing, Racism, Zionism, Timeless or most popular, War Crimes | , , , , , , | Leave a comment

A Hundred Deir Yassin and Counting: Beit Daras and the Buried History of Massacres

The invasion of Beit Daras following the last battle in May 1948. (Photo: Palestine Remembered)

The invasion of Beit Daras following the last battle in May 1948. (Photo: Palestine Remembered)
By Ramzy Baroud | Palestine Chronicle | April 17 2013 

Few with any sense of intellectual or historical integrity would still question the bloody massacre that took place in the village of Deir Yassin 65 years ago, claiming the lives of over 100 innocent Palestinians. Attempts at covering up the massacre have been dwarfed by grim details by well-respected historians, including some of Israel’s own.

Even narratives offered by historians such as Benny Morris – an honest researcher who remained committed to Zionism despite the ghastly history he had himself uncovered – presented a harrowing version of the events that unfolded on that day: “Whole families were riddled with bullets… men, women, and children were mowed down as they emerged from houses; individuals were taken aside and shot. Haganah intelligence reported ‘there were piles of dead. Some of the prisoners moved to places of incarceration, including women and children, were murdered viciously by their captors…”

It was the Irgun Zionist militias of Menachem Begin and the Stern Gang (Lehi) lead by Yitzhak Shamir that took credit for the infamy of that day; and both were rewarded generously for their ‘heroism’. The once wanted criminals rose to prominence to become Israeli Prime Ministers in later years.

The importance of the Deir Yassin massacre to historians often obscures important facts. One amongst them is that Deir Yassin was one of many massacres perpetrated by Zionist troops, including Haganah units. Another is that these militias had jointly formed the Israeli Defense Forces (IDF) following the official Israeli Declaration of Independence on May 14, 1948 despite their supposed differences during the conquest of Palestine. David Ben-Gurion had made his decision on May 26 and hesitated little to include both the Irgun and Lehi, alongside the Haganah. Not only did the leaders of the terrorist militias command respect and enjoy prestige within Israeli society, armed forces and the political elite, but the very murderers who butchered innocent men, women and children were empowered with bigger guns and continued to ‘serve’ and terrorize for many more years. Another often overlooked fact is that what started at Deir Yassin never truly finished. Sabra and Shatila, Jenin, Gaza and many more are only recreations of the same event.

But another sad reality also emerged and crystalized in the last 65 years. Since then the right to credible narration has still largely been reserved for Israeli historians. Most of these historians, whether sympathetic or otherwise, either played no part in that history, were privileged by its outcome or were themselves active participants. Still, it would take an Israeli historian to ‘discover’ a Palestinian massacre in some village at some point in time. For example, only when Israeli journalist Amir Gilat chose to run a story in Ma’ariv newspaper a few years ago, citing the research of Israeli master’s degree student Theodore Katz, did western media acknowledge the Tantura massacre. It mattered little that the descendants and relatives of 240 victims of that grief stricken village who were killed in cold blood by Alexandroni troops, never ceased remembering their loved ones. A ‘massacre’ is only a massacre when half-heartedly acknowledged by an Israeli historian no matter how long it takes for that admission to resurface.

Even Palestinian historians, at least those who are held accountable to the rules of western media and academia, find themselves borrowing mostly from Israeli sources, aggrandizing Israeli writers and celebrating Israeli historians who are supposedly more trustworthy than Palestinians. The logic has it that a sympathetic Israeli narrative would win greater acceptance by American or British audiences than one told by a Palestinian, even if the Palestinian historian had lived the event and experienced its every gory detail.

It is a travesty for the Palestinian narrative to live on borrowed analogies, borrowed histories and borrowed historians in order to enjoy an iota of credibility. This is just the tip of the iceberg and the problem runs much deeper than this.

In my last book, My Father Was a Freedom Fighter: Gaza’s Untold Story, I charted a detailed account of the Massacre of Beit Daras, when scores of inhabitants of that brave village, located in southern Palestine, were gunned down by Haganah troops only weeks after Deir Yassin inhabitants were massacred in a similar fashion. Beit Daras is the village from which my family was dispossessed to subsist in an impoverished refugee camp in Gaza.

Although Beit Daras was located at the north eastern part of the Gaza District in southern Palestine, it was high on the Zionist leadership agenda as early as the first months of conquest. The small village was one of a few villages and towns marked for destruction in Operation Nachshon and Harel aimed to completely cut off the Jaffa-Jerusalem landmass. The war for Beit Daras began early, as heavy shelling began between March 27-28, 1948, killing 9 villagers and destroying large areas of the village’s crops.

Several attempts had failed to drive the resilient villagers out. What turned out to be the last battle took place in mid-May. Um ‘Adel and Um Mohammed were two young girls in Beit Daras at the time. Now old women in Khan Younis refugee camp in Gaza, they helped me connect some of the pieces regarding what happened on that day. I provided their historically consistent accounts in my book on Gaza. Here are few excerpts:

Um ‘Adel recalls: “The women and children were told to leave because the news of the Deir Yassin massacre was spreading and with it lots of fear. We were told that the Jews not only massacre people, but rape women. The women had to be sent away, but the men wouldn’t leave. But so many of them were killed. The men fought like lions, and many were killed as well, including Abu Mansi Nassar and his two brothers, Ali Mohammed Hussain al-Osaji, and four youth from al-Maqadima.”

Um Mohammed elaborated: “The town was under bombardment, and it was surrounded from all directions. There was no way out. They surrounded it all, from the direction of Isdud, al-Sawafir and everywhere. We wanted to pursue a way out. The armed men (the Beit Daras fighters) said they were going to check on the road to Isdud, to see if it was open. They moved forward and shot few shots to see if someone would return fire. No one did. But they (the Zionist forces) were hiding and waiting to ambush the people. The armed men returned and told the people to evacuate the women and children. The people went out (including) those who were gathered at my huge house, the family house. There were mostly children and kids in the house.

“The armed men came and said, ‘the road to Isdud is open, evacuate the people.’ The Jews let the people get out, and then they whipped them with bombs and machine guns. More people fell than those who were able to run. My sister and I… started running through the fields; we’d fall and get up. My sister and I escaped together holding each other’s hand. The people who took the main road were either killed or injured, and those who went through the fields. The firing was falling on the people like sand. The bombs from one side and the machine guns from the other. The Jews were on the hill; there was a school and a water reservoir for people and the vegetables. They showered the people with machine guns. A lot of the people died and got injured.

But many fighters remained in Beit Daras. Not even a massacre would weaken their resolve. The wounded were gathered in many houses, but with little medical care to count on. Some of the dead were hurriedly buried. Many others were unreachable, lying in the sun amidst the blooming fields of spring.

Ramzy Baroud’s latest book is: My Father was A Freedom Fighter: Gaza’s Untold Story (Pluto Press).

Related posts:

  1. Film: Deir Yassin – The Agony
  2. Barghouti: Deir Yassin Massacre Has Not Ended
  3. April Memories: Deir Yassin Remembered
  4. Ben-Gurion and Massacre of Deir Yassin
  5. Sixty Years after Deir Yassin
  6. Deir Yassin massacre has not ended

April 17, 2013 Posted by | Ethnic Cleansing, Racism, Zionism, Timeless or most popular | , , , , , , , , , , | 1 Comment

Gantz Claims Zionist Entity Can Invade Iran

Al-Manar | April 17, 2013

The Israeli military chief claimed the Zionist entity can invade the Islamic Republic of Iran on its own.

Chief of Staff Lt. Gen Benny Gantz made the remarks in an interview on public radio in East al-QudsGantz (Jerusalem) on Tuesday, AFP reported.

“We have our plans and forecasts… If the time comes we’ll decide” on whether to take military action against Iran, he said.

Other Israeli officials made similar remarks, including Prime Minister Benjamin Netanyahu and Minister for Military Affairs Moshe Ya’alon.
Netanyahu said that US-engineered sanctions against Iran over its nuclear energy program might not be enough.

Ya’alon also said Iran’s nuclear energy program is the most dangerous threat to the world.

The United States, Israel and some of their allies have repeatedly accused Iran of pursuing non-civilian objectives in its nuclear energy program with the Israeli regime repeatedly threatening to attack Iran’s nuclear facilities based on the unsubstantiated allegation.

Iran rejects the allegations, arguing that as a committed signatory to the nuclear Non-Proliferation Treaty (NPT) and a member of the International Atomic Energy Agency (IAEA), it has the right to use nuclear technology for peaceful purposes.

April 17, 2013 Posted by | Militarism, War Crimes | , , , , , | 9 Comments

Pentagon to allocate $400 million to Iron Dome over next two years

Press TV – April 17, 2013

The US Defense Department plans to spend nearly 400 million dollars during the next two years on Israel’s Iron Dome missile system, despite budget cuts affecting the lives of many Americans.

Bloomberg reported on Tuesday that the Pentagon intends to allocate $220 million for the Israeli missile batteries in fiscal year 2014, which starts on October 1.

Washington also plans to spend $175.9 million in 2015.

If the budget is approved during the annual defense budget process, it will be added to the $486 million that Washington has already spent on the Israeli regime’s Iron Dome missile system during the past few years.

Meanwhile, US Defense Secretary Chuck Hagel is planning to travel to Israel in a few days.

“Our interests are very clear and common,” Hagel said at a US House hearing on Tuesday, adding, “I think the Israelis know that.”

The Israeli regime receives more than three billion dollars from the United States in direct foreign assistance every year.

Hagel recently reassured Tel Aviv that Washington would continue funding Israel’s costly Iron Dome.

On March 5, Hagel held a meeting with then Israeli Minister for Military Affairs Ehud Barak at the Pentagon, during which he voiced Washington’s “strong commitment” to backing funding for the Iron Dome, despite fiscal uncertainty for the US administration.

April 17, 2013 Posted by | Economics, Ethnic Cleansing, Racism, Zionism, Militarism, Progressive Hypocrite | , , , | 1 Comment

US medical system lets hospitals profit from botched surgeries, extra care

RT | April 17, 2013

American hospitals are financially discouraged from properly caring for their patients because, as a new study reveals, surgical complications and extra medical care result in higher profits generated from insurance companies.

The study’s results were published Tuesday in The Journal of the American Medical Association. In an editorial accompanying the findings, the authors recommended changing the American payment structure to put an end to a system that rewards hospitals that provide poor care.

Without such reforms, hospitals need to look no further than their bottom line to see that there’s no incentive to improve.

“It’s been known that hospitals are not rewarded for quality,” said study author and Harvard School of Public Health director Atul Gawande. “But it hadn’t been recognized exactly how much more money they make when harm is done.

“We found clear evidence that reducing harm and improving quality is perversely penalized in our current health care system,” said study author Sunil Eappen, who serves as the chief medical officer of the Massachusetts Eye and Ear Infirmary. Other authors hailed from the Boston Consulting Group, Harvard University School of Medicine, and the nonprofit Texas Health Resources.

It’s estimated that Americans and their insurance providers or government benefit programs spend $400 billion on surgery annually. Privately insured patients with surgery complications net hospitals 330 per cent more profit than privately insured patients who have a successful surgery. Elderly and disabled patients under a government Medicare plan provide hospitals with 190 per cent higher profit when their surgeries go wrong.

“If you personalize this and a relative is having a heart surgery, which gets complicated by pneumonia, I don’t think we would want a hospital’s profit to go up as a result of that pneumonia,” study co-author Barry Rosenberg, a partner in Boston Consulting Group’s health care practice, told the Washington Post.

The results highlight the longstanding problem with the American health care system’s for-profit foundation, which pays doctors for every service they provide – even if it’s done wrong.

“We have never seen hospitals that are actively trying to cause complications to make a profit,” said Gawande. “But we’ve seen a lot of hospitals where you say, ‘Why aren’t you investing in reducing risk, the way other industries do?’”

The results are based on the analysis of the records of 34,256 patients who had surgery in 2010 at one of 12 hospitals. Of that total, 1,820 people left surgery with one or more preventable complication including pneumonia, blood clots or infected incisions. The median stay of those patients would then quadruple to 14 days – whereupon insurers would average an additional $30,500.

“This is a clear indication that health care payment reform is necessary,” Gawande said. “Hospitals should gain, not lose, financially from reducing harm.”

April 17, 2013 Posted by | Corruption, Economics, Timeless or most popular | , | Leave a comment

FDA Let Drugs Approved on Fraudulent Research Stay on the Market

.

Retired FDA investigator Patrick Stone (Katie Hayes Luke for ProPublica)

On the morning of May 3, 2010, three agents of the Food and Drug Administration descended upon the Houston office of Cetero Research, a firm that conducted research for drug companies worldwide.

Lead agent Patrick Stone, now retired from the FDA, had visited the Houston lab many times over the previous decade for routine inspections. This time was different. His team was there to investigate a former employee’s allegation that the company had tampered with records and manipulated test data.

When Stone explained the gravity of the inquiry to Chinna Pamidi, the testing facility’s president, the Cetero executive made a brief phone call. Moments later, employees rolled in eight flatbed carts, each double-stacked with file boxes. The documents represented five years of data from some 1,400 drug trials.

Pamidi bluntly acknowledged that much of the lab’s work was fraudulent, Stone said. “You got us,” Stone recalled him saying.

Based partly on records in the file boxes, the FDA eventually concluded that the lab’s violations were so “egregious” and pervasive that studies conducted there between April 2005 and August 2009 might be worthless.

The health threat was potentially serious: About 100 drugs, including sophisticated chemotherapy compounds and addictive prescription painkillers, had been approved for sale in the United States at least in part on the strength of Cetero Houston’s tainted tests. The vast majority, 81, were generic versions of brand-name drugs on which Cetero scientists had often run critical tests to determine whether the copies did, in fact, act the same in the body as the originals. For example, one of these generic drugs was ibuprofen, sold as gelatin capsules by one of the nation’s largest grocery-store chains for months before the FDA received assurance they were safe.

The rest were new medications that required so much research to win approval that the FDA says Cetero’s tests were rarely crucial.

Stone said he expected the FDA to move swiftly to compel new testing and to publicly warn patients and doctors.

Instead, the agency decided to handle the matter quietly, evaluating the medicines with virtually no public disclosure of what it had discovered. It pulled none of the drugs from the market, even temporarily, letting consumers take the ibuprofen and other medicines it no longer knew for sure were safe and effective. To this day, some drugs remain on the market despite the FDA having no additional scientific evidence to back up the safety and efficacy of these drugs.

By contrast, the FDA’s transatlantic counterpart, the European Medicines Agency, has pulled seven Cetero-tested medicines from the market.

The FDA also has moved slowly to shore up the science behind the drugs. Twice the FDA announced it was requiring drug makers to repeat, reanalyze or audit many of Cetero’s tests, and to submit their findings to the agency. Both times the agency set deadlines, yet it has allowed some companies to blow by them.

Today, six months after the last of those deadlines expired and almost three years after Cetero’s misconduct was discovered, the FDA has received the required submissions for just 53 drugs. The agency says most companies met the deadlines but acknowledged that “a few have not yet submitted new studies.”

Other companies, it said, have not submitted new research because they removed their drugs from the market altogether.

For its part, the FDA has finished its review of just 21 of the 53 submissions it has received, raising the possibility that patients are taking medications today that the agency might pull off the market tomorrow.

To this day, the agency refuses to disclose the names of the drugs it is reassessing, on the grounds that doing so would expose “confidential commercial information.” ProPublica managed to identify five drugs that used Cetero tests to help win FDA approval.

FDA officials defended the agency’s handling of the Cetero case as prudent and scientifically sound, noting that the agency has found no discrepancies between any original drug and its generic copy and no sign that any patients have been harmed.

“It is non-trivial to have to redo all this, to withdraw drugs, to alarm the public and the providers for a large range of drugs,” said Janet Woodcock, the director of the FDA’s Center for Drug Evaluation and Research. “There are consequences. To repeat the studies requires human experimentation, and that is not totally without risk.”

Woodcock added that an agency risk assessment found the potential for harm from drugs tested by Cetero to be “quite low,” an assessment she said has been “confirmed” by the fact that no problems have been found in the drugs the agency has finished reviewing.

She declined to release the risk assessment or detail its design. A subsequent statement from the agency described the assessment as “fluid” and “ongoing.” The FDA also has not released its 21 completed reviews, which ProPublica has requested.

Some experts say that by withholding so much information in the Cetero case the FDA failed to meet its obligations to the public.

“If there are problems with the scientific studies, as there have been in this case, then the FDA’s review of those problems needs to be transparent,” said David Kessler, who headed the FDA from 1990 to 1997 and who is now a professor at the University of California at San Francisco. Putting its reviews in public view would let the medical community “understand the basis for the agency’s actions,” he said. “FDA may be right here, but if it wants public confidence, they should be transparent. Otherwise it’s just a black box.”

Another former senior FDA official, who spoke on condition of anonymity, also felt the FDA had moved too slowly and secretively. “They’re keeping it all in the dark. It’s not transparent at all,” he said.

By contrast, the European Medicines Agency has provided a public accounting of the science behind all the drugs it has reviewed. Its policy, the EMA said in response to questions, is to make public “all review procedures where the benefit-risk balance of a medicine is under scrutiny.”

Woodcock dismissed comparisons to the EMA. “Europe had a smaller handful of drugs,” she said, “and they may not have engaged in as extensive negotiation and investigations with the company as we did.”

She said the FDA would have disclosed more, including the names of drugs, had it believed there was a risk to public health. “We believe that this did not rise to the level where the public should be notified,” she said. “We felt it would result in misunderstanding and inappropriate actions.”

In a written response to Kessler’s comments, the FDA said, “We’ve been as transparent as possible given the legal protections surrounding an FDA investigation of this or any type. The issue is not a lack of transparency but rather the difficulty of explaining why the problems we identified at Cetero, which on their face would appear to be highly significant in terms of patient risk, fortunately were not.”

Still, the FDA’s secrecy has had other ramifications. Some of Cetero’s suspect research made its way unchallenged into the peer-reviewed scientific literature on which the medical community relies. In one case, a researcher and a journal editor told ProPublica they had no idea the Cetero tests had been called into doubt.

Cetero, in correspondence with the FDA, conceded misconduct. And in an interview, Cetero’s former attorney, Marc Scheineson, acknowledged that chemists at the Houston facility committed fraud but said the problem was limited to six people who had all been fired.

“There is still zero evidence that any of the test results…were wrong, inaccurate, or incorrect,” he said. Scheineson called the FDA’s actions “overkill” and said they led to the demise of Cetero and its successor company.

In 2012, the company filed for Chapter 11 bankruptcy and emerged with a new name, PRACS Institute. PRACS, in turn, filed for bankruptcy on March 22 of this year. A PRACS spokesperson said the company had closed the Houston facility in October 2012.

Pamidi, the Cetero executive who provided the carts of file boxes, declined to comment.

As for Stone, the former FDA investigator, he said he was disturbed by the agency’s decisions.

“They could have done more,” he said. “They should have done more.”

‘We Should Have Been Told’

Cross-checking U.S. and European public records, including regulatory filings, scientific studies and civil lawsuits, ProPublica was able to identify a few of the drugs that are on the U.S. market because of tests performed at Cetero’s Houston lab (see chart.) There is no evidence that patients have suffered harm from these drugs; the FDA says it has detected no increase in reports of side effects or lack of efficacy among Cetero-tested medications.

To be sure, just because a crucial study is deemed potentially unreliable does not mean that a drug is unsafe or ineffective. What it does mean is that the FDA’s scientific basis for approving that drug has been undermined.

The risks are real, academic experts say, particularly for drugs such as blood thinners and anti-seizure medications that must be given at very specific doses. And generic versions of drugs have been known to act differently from name-brand products (see accompanying story.)

There is no indication the generic ibuprofen gelatin capsules hurt anyone, but their case shows how the FDA left a drug on the market for months without confirmation that the drug was equivalent to the name brand.

The capsules were manufactured by Banner Pharmacaps and carried by Supervalu, a grocery company that operates or licenses more than 2,400 stores across the United States, including Albertson’s, Jewel-Osco, Shop ‘n Save, Save-A-Lot, and Shoppers Food & Pharmacy.

Cetero had performed a key analysis to show that the capsules were equivalent to other forms of the drug. Banner, the drug’s maker, said the FDA first alerted it to the problems at Cetero in August 2011. The FDA required drug companies to redo many of Cetero’s tests, but, a spokesperson for Banner wrote in an email, “We received no directive from FDA to recall or otherwise interrupt manufacture of the product.”

Banner said it repeated the tainted Cetero tests at a different research firm, and the FDA said it received the new data in January 2012 — leaving a gap of at least five months when the FDA knew the drug was on the market without a rock-solid scientific basis.

An FDA spokesperson wrote in an email that the agency found the new studies Banner submitted “acceptable” and told Banner it had no further questions.

A spokesperson for Supervalu told ProPublica it purchased the ibuprofen from a supplier, which has assured the grocery company that “there are no issues with the product.”

According to U.S. and European records, another one of the drugs approved based on research at Cetero’s troubled Houston lab was a chemotherapy drug known as Temodar for Injection.

Temodar was originally approved in 1999 as a capsule to fight an aggressive brain cancer, glioblastoma multiforme. Some patients, however, can’t tolerate taking the medication orally, so drug maker Schering-Plough decided to make an intravenous form of the drug.

To get Temodar for Injection approved, the FDA required what it called a “pivotal” test comparing the well-established capsule form of Temodar to the form injected directly into the bloodstream.

Cetero Houston conducted that test, comparing blood samples of patients who received the capsule to samples of those who got the injection to determine if the same amount of the drug was reaching the bloodstream. This test is crucial, particularly in the case of Temodar, where there was a question about the right dosing regimen of the injectable version. If too little drug gets into the blood, the cancer could continue to grow unabated. If too much gets in, the drug’s debilitating side effects could be even worse.

Cetero performed the test between September 2006 and October 2007, according to documents from the European Medicines Agency, and FDA records indicate that same test was used to win approval in the U.S.

In 2011, the FDA notified Merck & Co., which had acquired Schering-Plough, about the problems with Cetero’s testing. In April 2012, the FDA publicly announced that analyses done by Cetero during the time when it performed the Temodar work would have to be redone. But according to Merck spokesman Ronald Rogers, the FDA has not asked Merck for any additional analyses to replace the questionable study.

The FDA declined to answer specific questions about the Temodar case, saying to do so would reveal confidential commercial information. But Woodcock said that in some cases, drug manufacturers had submitted alternative test results to the FDA that satisfied the agency that no retesting was necessary for specific drugs.

The FDA never removed Temodar for Injection from the market. The European Medicines Agency also kept the injection form of the drug on the market, but the two agencies handled their decision in sharply different ways.

The EMA has publicly laid out evidence — including studies not performed by Cetero — for why it believes the benefits of the injection drug outweigh its risks. But in the United States, the FDA has kept silent. To this day, Temodar’s label — the single most important way the FDA communicates the risks and benefits of medication — still displays data from the dubious Cetero study. (The label of at least one other drug, a powerful pain reliever marketed as Lazanda, also still displays questionable Cetero data.)

Woodcock said the agency hadn’t required manufacturers to alter their labels because, despite any question about precise numerical precision, the FDA’s overall recommendation had not changed.

In a written response to questions, Merck said it “stands behind the data in the TEMODAR (temozolomide) label.” The company said it learned about “misconduct at a contract research organization (CRO) facility in Houston” from the FDA and that it cooperated with investigations by the FDA and its European counterpart. It said that Cetero had performed no other studies for Merck.

Even one of the researchers involved in evaluating injectable Temodar didn’t know that the FDA had flagged Cetero’s analysis as potentially unreliable until contacted by a reporter for this story.

Dr. Max Schwarz, an oncologist and clinical professor at Monash University in Melbourne, Australia, treated some brain-cancer patients with the experimental injectable form of Temodar and others with the capsule formulation. Blood from his patients was sent to Cetero’s Houston lab for analysis.

Schwarz said he still has confidence in the injectable form of the drug, but said that he was “taken aback” when a reporter told him that the FDA had raised questions about the analysis. “I think we should have been told,” he said.

Suspect research conducted by Cetero Houston was not only used to win FDA approval but was also submitted to peer-reviewed scientific journals. Aided by the FDA’s silence, those articles remain in the scientific literature with no indication that they might, in fact, be compromised. For example, based on Cetero’s work, an article in the journal Cancer Chemotherapy and Pharmacology purports to show that Temodar for Injection is equivalent to Temodar capsules.

Edward Sausville, co-editor-in-chief of the journal, said in an email that the first he heard that something might be wrong with the Cetero research was when a reporter contacted him for this story. He also said the publisher of the journal would conduct a “review of relevant records pertinent to this case.”

‘There’s Always Something Missing’

During his years of inspecting the Houston lab, the FDA’s Stone said he often had the sense that something wasn’t right. When he went to other contract research firms and asked for data on a trial, they generally produced an overwhelming amount of paper: records of failed tests, meticulous explanations of how the chemists had made adjustments, and more.

Cetero’s records, by contrast, showed very clean, error-free procedures. As Stone and his colleagues dug through the data, though, they often found gaps. When pressed, Cetero officials would often produce additional data — data that ought to have been in the files originally handed over to the FDA.

Stone said, “We should have looked back and said, ‘Wait a minute, there’s always something missing from the studies from here. Why?'”

One reason, the FDA would determine, was that Cetero’s chemists were taking shortcuts and other actions prohibited by the FDA’s Good Laboratory Practice guidelines, which set out such matters as how records must be kept and how tests must be performed.

Stone and his FDA colleagues might never have realized Cetero was engaging in misconduct if a whistleblower hadn’t stepped forward.

Cashton J. Briscoe operated a liquid chromatography-tandem mass spectrometry device, or “mass spec,” a sensitive machine that measures the concentration of a drug in the blood.

He took blood samples prepared by Cetero chemists and used mass specs to perform “runs” — tests to see how much of a drug is in patients’ blood — that must always be performed with control samples. Often those controls show readings that are clearly wrong, and chemists have to abort runs, document the failure, recalibrate the machines, and redo the whole process.

But Cetero paid its Houston chemists based on how many runs they completed in a day. Some chemists doubled or even tripled their income by squeezing in extra tests, according to time sheets entered as evidence in a lawsuit filed in U.S. District Court in Houston by six chemists seeking overtime payments. Briscoe thought several chemists were cutting corners — by using the control-sample readings from one run in other runs, for example.

Attorney Scheineson, who represented Cetero during the FDA’s investigation, acknowledged that the Houston lab’s compensation system was “crappy” and that a handful of “dishonest” chemists at the Houston facility committed fraud.

In April 2009, Briscoe blew the whistle in a letter to the company written by his lawyer, reporting that “many of the chemists were manipulating and falsifying data.” Soon thereafter, Briscoe told the company that he had documented the misconduct. According to Stone and documents reviewed by ProPublica, Briscoe had photographic evidence that mass spec operators had switched the quality control samples between different runs; before-and-after copies of documents with the dates and other material changed; and information about a shadow computer filing system, where data from failed runs could be stored out of sight of FDA inspectors.

On June 5, apparently frustrated with Cetero’s response, Briscoe went a step further and called the FDA’s Dallas office. He agreed to meet Stone the following Monday, but never showed. Stone called him, as did other FDA officials, but Briscoe had changed his mind and clammed up.

Still, Stone’s brief phone conversation with Briscoe reminded the agent of all those suspiciously clean records he had seen at Cetero over the years. “Now that you have a bigger picture,” Stone recalled, “you’re like, ‘Oh, some of this stuff is cooked.'”

Two days after Stone’s aborted meeting with Briscoe, Cetero informed the FDA that an employee had made allegations of misconduct and that the company had hired an outside auditor to review five years’ worth of data. That led to months of back-and-forth between the agency and Cetero that culminated when Stone and his inspectors arrived in Houston in May 2010.

Two teams of FDA investigators eventually confirmed Briscoe’s main allegations and cited the company for falsifying records and other violations of Good Laboratory Practice. The net effect of the misconduct was far-reaching, agency officials wrote in a July 2011 letter:

“The pervasiveness and egregious nature of the violative practices by your firm has led FDA to have significant concerns that the bioequivalence and bioavailability data generated at the Cetero Houston facility from April 1, 2005, to June 15, 2010 … are unreliable.”

Bioequivalence studies measure whether a generic drug acts the same in the body as the name-brand drug; bioavailability studies measure how much drug gets into a patient’s system.

The FDA’s next step was to try to determine which drugs were implicated — information the agency couldn’t glean from its own records.

“We couldn’t really tell — because most of the applications we get are in paper — which studies were actually linked to the key studies in an application without asking the application holders,” the FDA’s Woodcock said. “So we asked the application holders,” meaning the drug manufacturers.

In the interim, the FDA continued to investigate processes and procedures at Cetero.

“We put their operations under a microscope,” said Woodcock. A team of clinical pharmacologists, statisticians and IT experts conducted a risk analysis of the problems at Cetero, she said, and they “concluded that the risk of a misleading result was very low given how the studies were done, how the data were captured and so forth.”

In April 2012, nearly three years after Briscoe first alerted the FDA to problems at Cetero, and nearly two years after Cetero handed over its documentation to inspectors, the FDA entered into a final agreement with the company. Drug makers would need to redo tests conducted at the company’s Houston facility between April 1, 2005 and Feb. 28, 2008, if those studies had been part of a drug application submitted to the FDA. If stored blood samples were still usable, they could be reanalyzed. If not, the entire study would need to be repeated, the FDA said. The agency set a deadline of six months.

Cetero tests done between March 1, 2008 and Aug. 31, 2009 would be accepted only if they were accompanied by an independent data integrity audit.

Analyses done after Sept. 1, 2009 would not require retesting. The FDA said that Cetero had issued a written directive on Sept. 1, 2009, ordering one kind of misconduct to stop, which was why it did not require any action on Cetero Houston studies after that date. According to public documents, however, the agency’s inspectors “found continued deficiencies” that persisted into December 2010.

In response to questions, the FDA said the problem period “was subsequently narrowed as more information regarding Cetero’s practices became available.”

A year after concluding its final agreement with Cetero, the FDA’s review is still not finished. “Without the process being public it’s hard to know, but it seems that this has been going on for too long,” said Kessler, the former FDA chief.

“The process has been long,” the FDA said, “because of the number of products involved and our wish to be thorough and accurate in both our requests for and our review of the data.”

Cetero’s attorney Scheineson said the FDA scaled back its requirements because it finally talked with company officials. He noted that Cetero had tried repeatedly to talk with the FDA before the agency issued its strongly worded July 2011 letter, and that more than 1,000 employees have since lost their jobs.

“If you would get an honest assessment from the leaders of the agency,” he said, “I think in retrospect they would have argued that this was overkill here and that they should have had input from the company before essentially going public with that death sentence.”

“I’m not sure what is meant by ‘death sentence,'” an FDA spokesperson wrote in response, “but our first priority was and is patient safety and we proceeded to conduct the investigation toward that objective.”

‘Should I Be Proud of This?’

The FDA’s Stone draws little satisfaction from unraveling the problems at Cetero.

There are thousands of bioequivalence studies done every year, he pointed out, with each study generating thousands of pages of paper records. “Do you really think we’re going to look at 100 percent of them? We’re going to look at maybe 5 percent if we’re lucky,” he said. “Sometimes 1 percent.”

Still, given how often he and other FDA teams had inspected the Houston lab, he thinks regulators should have spotted Cetero’s misconduct sooner.

“In hindsight I look back and I’m like, ‘Wow, should I be proud of this?'” he said. “It’s cool that I was part of it, but it’s crap that we didn’t catch it five years ago. How could we let this go so long?”

Rob Garver can be reached at rob.garver@propublica.org, and Charles Seife can be reached at cgseife@nasw.org.

Research assistance for this story was contributed by Nick Stockton, Christine Kelly, Lily Newman, Joss Fong and Sarah Jacoby of the Science, Health, and Environmental Reporting Program at NYU.

April 17, 2013 Posted by | Deception | , , , , , | Leave a comment

Israel’s Iron Dome Fails to Intercept Eilat Rockets

Al-Manar | April 17, 2013

The Zionist entity’s vaunted Iron Dome anti-missile system failed to intercept at least two rockets fired from Egypt’s Sinai Peninsula. The two rockets hit the occupied Red Sea resort town of Eilat early on Wednesday with no casualties reported.

Israeli military sources said the vaunted Iron Dome anti-missile system, which was recently deployed around Eilat, did not engage to intercept the rockets.

“We’ve found two explosion sites in the city, we’ve also closed off the airport as a precaution,” police spokesman Micky Rosenfeld told AFP, saying one landed in “an open area close to one of the neighborhoods.”

He said the sirens had sounded but that there were no initial reports of casualties. “Bomb disposal experts are searching the area,” Rosenfeld said.
The military spokesman said both rockets had struck open areas.

“There were two rockets fired from Sinai, both landed in open spaces,” he said. Later on, Israeli website, Haaretz, reported that the airport in Eilat reopened.

Egypt denied that rockets were fired from its territories, and senior military official said troops were “investigating” the incident.

Hours later, a Salafi group called the Mujahedeen Shura Council posted a statement online saying its militants had “managed to target occupied Eilat with two Grad rockets” without saying where they were fired from.

April 17, 2013 Posted by | Aletho News | , , , , , | 1 Comment

EPIC Appeals FOIA Decisions Concerning Body Scanner Information

Electronic Privacy Information Center – April 16, 2013

EPIC has filed appeals in two Freedom of Information Act cases seeking documents related to airport body scanners from the Department of Homeland Security and the Transportation Security Administration.

EPIC filed FOIA requests with the agencies seeking records related to radiation risks from body scanners and the threat detection software the machines use.

The TSA is currently developing formal rules for the use of body scanners in response to a court order in one of EPIC’s previous cases.

Body scanners allow routine digital strip searches of individuals who are not suspected of any crime.

For more information, see EPIC: Radiation Risks lawsuit and EPIC: ATR lawsuit, and EPIC: Suspension of Body Scanner Program.

April 17, 2013 Posted by | Civil Liberties, Full Spectrum Dominance | , , , , , , , | Leave a comment